Stearoyl coenzyme A desaturase 1 is associated with hepatitis C virus replication complex and regulates viral replication

Journal of Virology

Volumn 88, Issue 21, 2014, Pages 12311-12325

  Nguyen, Lam N ^a   Lim, Yun Sook ^a   Pham, Long V ^a   Shin, Hae Young ^a   Kim, Yong Sun ^a   Hwang, Soon B ^a  

^a Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE 1; NONSTRUCTURAL PROTEIN 4B; OLEIC ACID; PALMITOLEIC ACID; SMALL INTERFERING RNA; VIRUS PROTEIN; ACYL COENZYME A DESATURASE; SCD1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; GENE TARGETING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTRACELLULAR MEMBRANE; MICROENVIRONMENT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS MORPHOLOGY; VIRUS REPLICATION; CELL LINE; CELL MEMBRANE; GENETIC SCREENING; HEPACIVIRUS; HOST PATHOGEN INTERACTION; LIVER CELL; METABOLISM; PHYSIOLOGY; ULTRASTRUCTURE; VIROLOGY;

CELL LINE; CELL MEMBRANE; GENE KNOCKDOWN TECHNIQUES; GENETIC TESTING; HEPACIVIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROSCOPY, ELECTRON; STEAROYL-COA DESATURASE; VIRUS REPLICATION;

EID: 84907992495     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01678-14     Document Type: Article

References (49)

1. Hoofnagle JH. 2002. Course and outcome of hepatitis C. Hepatology 36:S21-S29. http://dx.doi.org/10.1053/jhep.2002.36227.
2. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. 2013. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57:1333-1342. http://dx.doi.org/10.1002/hep.26141.
3. Carlson A, Gregorich Z, Striker R. 2013. Telaprevir to boceprevir switch highlights lack of cross-reactivity. Clin. Infect. Dis. 56:552-554. http://dx.doi.org/10.1093/cid/cis960.
4. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. 1998. Host-and disease-specific factors affecting steatosis in chronic hepatitis C. J. Hepatol. 29:198-206. http://dx.doi.org/10.1016/S0168-8278(98)80004-4.
5. Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R, Wieland S, Bukh J, Purcell RH, Schultz PG, Chisari FV. 2002. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. U. S. A. 99:15669-15674. http://dx.doi.org/10.1073/pnas.202608199.
6. Bigger CB, Guerra B, Brasky KM, Hubbard G, Beard MR, Luxon BA, Lemon SM, Lanford RE. 2004. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J. Virol. 78:13779-13792 http://dx.doi.org/10.1128/JVI.78.24.13779-13792.2004.
7. Waris G, Felmlee DJ, Negro F, Siddiqui A. 2007. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J. Virol. 81: 8122-8130. http://dx.doi.org/10.1128/JVI.00125-07.
8. Park EM, Nguyen LN, Lim YS, Hwang SB. 2014. Farnesyl-diphosphate farnesyltransferase 1 regulates hepatitis C virus propagation. FEBS Lett. 588:1813-1820. http://dx.doi.org/10.1016/j.febslet.2014.03.043.
9. Enoch HG, Catalá A, Strittmatter P. 1976. Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid. J. Biol. Chem. 251: 5095-5103.
10. Sampath H, Ntambi JM. 2011. The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation. Ann. N. Y. Acad. Sci. 1243: 47-53. http://dx.doi.org/10.1111/j.1749-6632.2011.06303.x.
11. Miyazaki M, Flowers MT, Sampath H, Chu K, Otzelberger C, Liu X, Ntambi JM. 2007. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab. 6:484-496. http://dx.doi.org/10.1016/j.cmet.2007.10.014.
12. Budhu A, Roessler S, Zhao X, Yu Z, Forgues M, Ji J, Karoly E, Qin LX, Ye QH, Jia HL, Fan J, Sun HC, Tang ZY, Wang XW. 2013. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology 144:1066-1075. http://dx.doi.org /10.1053/j.gastro.2013.01.054.
13. Moriya K, Todoroki T, Tsutsumi T, Fujie H, Shintani Y, Miyoshi H, Ishibashi K, Takayama T, Makuuchi M, Watanabe K, Miyamura T, Kimura S, Koike K. 2001. Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humans. Biochem. Biophys. Res. Commun. 281:1207-1212 http://dx.doi.org/10.1006/bbrc.2001.4523.
14. Miyoshi H, Moriya K, Tsutsumi T, Shinzawa S, Fujie H, Shintani Y, Fujinaga H, Goto K, Todoroki T, Suzuki T, Miyamura T, Matsuura Y, Yotsuyanagi H, Koike K. 2011. Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein. J. Hepatol. 54:432-438. http://dx.doi.org/10.1016/j.jhep.2010.07.039.
15. Lim YS, Tran HT, Park SJ, Yim SA, Hwang SB. 2011. Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation. J. Virol. 85:8777-8788. http://dx.doi.org/10.1128/JVI.02533-10.
16. Park CY, Choi SH, Kang SM, Kang JI, Ahn BY, Kim H, Jung G, Choi KY, Hwang SB. 2009. Nonstructural 5A protein activates β-catenin signaling cascades: implication of hepatitisCvirus-induced liver pathogenesis. J. Hepatol. 51:853-864. http://dx.doi.org/10.1016/j.jhep.2009.06.026.
17. Windisch MP, Frese M, Kaul A, Trippler M, Lohmann V, Bartenschlager R. 2005. Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J. Virol. 79:13778-13793 http://dx.doi.org/10.1128/JVI.79.21.13778-13793.2005.
18. Pham LV, Ngo HTT, Lim YS, Hwang SB. 2012. Hepatitis C virus non-structural 5B protein interacts with cyclin A2 and regulates viral propagation. J. Hepatol. 57:960-966. http://dx.doi.org/10.1016/j.jhep.2012.07.006.
19. Kang SM, Lim S, Won SJ, Shin YJ, Lim YS, Ahn BY, Hwang SB. 2011. c-Fos regulates hepatitis C virus propagation. FEBS Lett. 585:3236-3244. http://dx.doi.org/10.1016/j.febslet.2011.08.041.
20. Ngo HTT, Pham LV, Kim JW, Lim YS, Hwang SB. 2013. Modulation of mitogen-activated protein kinase-activated protein kinase 3 by hepatitis C virus core protein. J. Virol. 87:5718-5731. http://dx.doi.org/10.1128/JVI.03353-12.
21. Tan SH, Shui G, Zhou J, Shi Y, Huang J, Xia D, Wenk MR, Shen HM. 2014 Critical role of SCD1 in autophagy regulation via lipogenesis and lipid rafts-coupled AKT-FOXO1 signaling pathway. Autophagy 10:226-242 http://dx.doi.org/10.4161/auto.27003.
22. Weaver AK, Olsen ML, McFerrin MB, Sontheimer H. 2007. BK channels are linked to inositol 1,4,5-triphosphate receptors via lipid rafts: a novel mechanism for coupling [Ca(2+)](i) to ion channel activation. J. Biol. Chem. 282:31558-31568. http://dx.doi.org/10.1074/jbc.M702866200.
23. Saxena V, Lai CK, Chao TC, Jeng KS, Lai MM. 2012. Annexin A2 is involved in the formation of hepatitis C virus replication complex on the lipid raft. J. Virol. 86:4139-4150. http://dx.doi.org/10.1128/JVI.06327-11.
24. Wang H, Perry JW, Lauring AS, Neddermann P, De Francesco R, Tai AW. 2014. Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required forHCVreplication membrane integrity and cholesterol trafficking. Gastroenterology 146:1373-1385 e1311. http://dx.doi.org/10.1053/j.gastro.2014.02.002.
25. Cousin SP, Hügl SR, Wrede CE, Kajio H, Myers MG, Jr, Rhodes CJ. 2001 Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic β-cell line INS-1. Endocrinology 142:229-240. http://dx.doi.org/10.1210/endo.142.1.7863.
26. Garcia-Serrano S, Moreno-Santos I, Garrido-Sanchez L, Gutierrez-Repiso C, Garcia-Almeida JM, Garcia-Arnes J, Rivas-Marin J, Gallego-Perales JL, Garcia-Escobar E, Rojo-Martinez G, Tinahones F, Soriguer F, Macias-Gonzalez M, Garcia-Fuentes E. 2011. Stearoyl-CoA desaturase-1 is associated with insulin resistance in morbidly obese subjects. Mol. Med. 17:273-280. http://dx.doi.org/10.2119/molmed.2010.00078.
27. Liu G, Lynch JK, Freeman J, Liu B, Xin Z, Zhao H, Serby MD, Kym PR, Suhar TS, Smith HT, Cao N, Yang R, Janis RS, Krauser JA, Cepa SP, Beno DWA, Sham HL, Collins CA, Surowy TK, Camp HS. 2007. Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors. J. Med. Chem. 50:3086-3100. http://dx.doi.org/10.1021 /jm070219p.
28. Shanklin J, Whittle E, Fox BG. 1994. Eight histidine residues are catalytically essential in a membrane-associated iron enzyme, stearoyl-CoA desaturase, and are conserved in alkane hydroxylase and xylene monooxygenase. Biochemistry 33:12787-12794. http://dx.doi.org/10.1021/bi00209a009.
29. Lou Y, Shanklin J. 2010. Evidence that the yeast desaturase Ole1p exists as a dimer in vivo. J. Biol. Chem. 285:19384-19390. http://dx.doi.org/10.1074/jbc.M110.125377.
30. Kapadia SB, Chisari FV. 2005. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. U. S. A. 102:2561-2566. http://dx.doi.org/10.1073/pnas.0409834102.
31. Bolte S, Cordelières FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224:213-232. http://dx.doi.org/10.1111/j.1365-2818.2006.01706.x.
32. Aizaki H, Lee KJ, Sung VM, Ishiko H, Lai MM. 2004. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324:450-461. http://dx.doi.org/10.1016/j.virol.2004.03.034.
33. Ntambi JM. 1999. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid. Res. 40:1549-1558.
34. Collins JM, Neville MJ, Hoppa MB, Frayn KN. 2010. De novo lipogenesis and stearoyl-CoA desaturase are coordinately regulated in the human adipocyte and protect against palmitate-induced cell injury. J. Biol. Chem. 285:6044-6052. http://dx.doi.org/10.1074/jbc.M109.053280.
35. Gouttenoire J, Roingeard P, Penin F, Moradpour D. 2010. Amphipathic-helix AH2 is a major determinant for the oligomerization of hepatitis C virus nonstructural protein 4B. J. Virol. 84:12529-12537. http://dx.doi.org/10.1128/JVI.01798-10.
36. Romero-Brey I, Merz A, Chiramel A, Lee JY, Chlanda P, Haselman U, Santarella-Mellwig R, Habermann A, Hoppe S, Kallis S, Walther P, Antony C, Krijnse-Locker J, Bartenschlager R. 2012. Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog. 8:e1003056. http://dx.doi.org/10.1371/journal.ppat.1003056.
37. Paul D, Hoppe S, Saher G, Krijnse-Locker J, Bartenschlager R. 2013. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment. J. Virol. 87:10612-10627. http: //dx.doi.org/10.1128/JVI.01370-13.
38. Gao L, Aizaki H, He JW, Lai MM. 2004. Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J. Virol. 78: 3480-3488. http://dx.doi.org/10.1128/JVI.78.7.3480-3488.2004.
39. Aligo J, Jia S, Manna D, Konan KV. 2009. Formation and function of hepatitis C virus replication complexes require residues in the carboxyterminal domain of NS4B protein. Virology 393:68-83. http://dx.doi.org /10.1016/j.virol.2009.07.033.
40. Xu S, Pei R, Guo M, Han Q, Lai J, Wang Y, Wu C, Zhou Y, Lu M, Chen X. 2012. Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly. J. Virol. 86:13025-13037. http://dx.doi.org /10.1128/JVI.01785-12.
41. Ciesek S, Steinmann E, Wedemeyer H, Manns MP, Neyts J, Tautz N, Madan V, Bartenschlager R, von Hahn T, Pietschmann T. 2009. Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A. Hepatology 50:1638-1645. http://dx.doi.org/10.1002/hep.23281.
42. Kaul A, Stauffer S, Berger C, Pertel T, Schmitt J, Kallis S, Lopez MZ, Lohmann V, Luban J, Bartenschlager R. 2009. Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. PLoS Pathog. 5:e1000546. http://dx.doi.org/10.1371/journal.ppat.1000546.
43. Lee WM, Ishikawa M, Ahlquist P. 2001. Mutation of host delta9 fatty acid desaturase inhibits brome mosaic virus RNA replication between template recognition and RNA synthesis. J. Virol. 75:2097-2106. http://dx.doi.org/10.1128/JVI.75.5.2097-2106.2001.
44. Lee WM, Ahlquist P. 2003. Membrane synthesis, specific lipid requirements, and localized lipid composition changes associated with a positivestrand RNA virus RNA replication protein. J. Virol. 77:12819-12828. http://dx.doi.org/10.1128/JVI.77.23.12819-12828.2003.
45. Cordomí A, Prades J, Frau J, Vögler O, Funari SS, Perez JJ, Escribá PV, Barceló F. 2010. Interactions of fatty acids with phosphatidylethanolamine membranes: X-ray diffraction and molecular dynamics studies. J. Lipid. Res. 51:1113-1124. http://dx.doi.org/10.1194/jlr.M003012.
46. Paul D, Romero-Brey I, Gouttenoire J, Stoitsova S, Krijnse-Locker J, Moradpour D, Bartenschlager R. 2011. NS4B self-interaction through conserved C-terminal elements is required for the establishment of functional hepatitis C virus replication complexes. J. Virol. 85:6963-6976. http://dx.doi.org/10.1128/JVI.00502-11.
47. Alemany R, Terés S, Baamonde C, Benet M, Vögler O, Escribá PV. 2004 2-Hydroxyoleic acid: a new hypotensive molecule. Hypertension 43:249-254. http://dx.doi.org/10.1161/01.HYP.0000107778.85528.b5.
48. Kinnunen PK. 1996. On the molecular-level mechanisms of peripheral protein-membrane interactions induced by lipids forming inverted nonlamellar phases. Chem. Phys. Lipids 81:151-166.
49. Lyn RK, Singaravelu R, Kargman S, O' Hara S, Chan H, Oballa R, Huang Z, Jones DM, Ridsdale A, Russell RS, Partridge AW, Pezacki JP. 2014 Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes. Sci. Rep. 4:4549. http://dx.doi.org /10.1038/srep04549.